Walsh M P, Sutherland C, Scott-Woo G C
Department of Medical Biochemistry, Faculty of Medicine, University of Calgary, Alberta, Canada.
Biochem Pharmacol. 1988 Apr 15;37(8):1569-80. doi: 10.1016/0006-2952(88)90020-2.
We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, caldesmon kinase and myosin light chain kinase) of the dihydropyridine Ca2+ channel blocker felodipine and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies. The cAMP phosphodiesterase was inhibited completely by felodipine and the p-chloro analogue with IC50 values of 3.7 and 1.5 microM respectively. The oxidized and t-butyl analogues were relatively ineffective in inhibiting cAMP phosphodiesterase. Felodipine and the p-chloro analogue inhibited the basal (Ca2+/calmodulin-independent) activity of cAMP phosphodiesterase as well as the calmodulin-stimulated activity. Calmodulin was relatively ineffective in preventing inhibition of cAMP phosphodiesterase by felodipine and the p-chloro analogue. These observations suggest that felodipine may act directly on the phosphodiesterase as well as through calmodulin. Felodipine and the p-chloro analogue inhibited Ca2+/calmodulin-dependent caldesmon kinase with similar potencies (IC50 = 17.4 microM), whereas the oxidized and t-butyl analogues caused no inhibition. Similarly, felodipine and the p-chloro analogue inhibited myosin light chain kinase activity whether the isolated 20 kD light chain (IC50 = 12.6 microM) or intact myosin (IC50 = 11.0 microM) was used as substrate. Inhibition in each case was prevented by excess calmodulin. The oxidized and t-butyl derivatives caused little or no inhibition. Finally, the effects of felodipine and the three analogues on two processes which are dependent on myosin phosphorylation were examined, namely the actin-activated Mg2+-ATPase activity of myosin and the assembly of myosin filaments. Felodipine and the p-chloro analogue inhibited the actin-activated Mg2+-ATPase activity of smooth muscle myosin (IC50 = 25.1 microM). The oxidized and t-butyl analogues exhibited no inhibition. Similarly, felodipine and the p-chloro analogue blocked myosin filament assembly induced by low concentrations of calmodulin, whereas the oxidized and t-butyl analogues did not. Again, inhibition of the actin-activated myosin Mg2+-ATPase and myosin filament assembly by felodipine and the p-chloro analogue could be reversed by raising the calmodulin concentration. These observations suggest that some of the pharmacological actions of felodipine on smooth muscle may involve inhibition of calmodulin-dependent enzymes which are functionally involved in the regulation of smooth muscle contraction.
我们研究了二氢吡啶类钙离子通道阻滞剂非洛地平及其三种具有不同药理活性的类似物(对氯、氧化型和叔丁基类似物)对三种钙调蛋白依赖性酶(环磷酸腺苷磷酸二酯酶、钙调蛋白激酶和肌球蛋白轻链激酶)活性的影响。非洛地平及对氯类似物可完全抑制环磷酸腺苷磷酸二酯酶,其半数抑制浓度(IC50)分别为3.7和1.5微摩尔/升。氧化型和叔丁基类似物对环磷酸腺苷磷酸二酯酶的抑制作用相对较弱。非洛地平及对氯类似物既能抑制环磷酸腺苷磷酸二酯酶的基础活性(不依赖钙/钙调蛋白),也能抑制钙调蛋白刺激的活性。钙调蛋白对非洛地平及对氯类似物抑制环磷酸腺苷磷酸二酯酶的作用影响相对较小。这些观察结果表明,非洛地平可能直接作用于磷酸二酯酶,也可能通过钙调蛋白发挥作用。非洛地平及对氯类似物对钙/钙调蛋白依赖性钙调蛋白激酶的抑制作用效力相似(IC50 = 17.4微摩尔/升),而氧化型和叔丁基类似物则无抑制作用。同样,无论以分离的20kD轻链(IC50 = 12.6微摩尔/升)还是完整的肌球蛋白(IC50 = 11.0微摩尔/升)作为底物,非洛地平及对氯类似物均能抑制肌球蛋白轻链激酶活性。在每种情况下,过量的钙调蛋白均可阻止抑制作用。氧化型和叔丁基衍生物几乎没有抑制作用。最后,研究了非洛地平及其三种类似物对两个依赖肌球蛋白磷酸化过程的影响,即肌球蛋白的肌动蛋白激活的镁离子 - 三磷酸腺苷酶活性和肌球蛋白丝的组装。非洛地平及对氯类似物抑制平滑肌肌球蛋白的肌动蛋白激活的镁离子 - 三磷酸腺苷酶活性(IC50 = 25.1微摩尔/升)。氧化型和叔丁基类似物无抑制作用。同样,非洛地平及对氯类似物可阻断低浓度钙调蛋白诱导的肌球蛋白丝组装,而氧化型和叔丁基类似物则不能。同样,提高钙调蛋白浓度可逆转非洛地平及对氯类似物对肌动蛋白激活的肌球蛋白镁离子 - 三磷酸腺苷酶和肌球蛋白丝组装的抑制作用。这些观察结果表明,非洛地平对平滑肌的某些药理作用可能涉及抑制钙调蛋白依赖性酶,这些酶在功能上参与平滑肌收缩的调节。